Effectiveness of antidepressants: Meta-analysis of dose-effect relationships in randomised clinical trials
Abstract
BACKGROUND: Antidepressant drugs are usually prescribed at low doses, possibly to avoid adverse reactions. No comprehensive review has addressed the issue of dose, clinical response and tolerability in a quantitative way. AIMS: To determine whether high doses of antidepressants are more effective than low doses, and how safety is affected by dose. METHOD: Trials comparing two or more doses of the same antidepressant were located, and all antidepressants administered were converted to the equivalent dose of imipramine. Generalised estimating equations were used to analyse percentage improvement and adverse event rate according to dose level. RESULTS: Thirty-three studies were identified. The dose level 100-200 mg imipramine equivalents showed an average improvement of 53% by 'intention-to-treat'. Higher doses were not accompanied by increased efficacy, while lower doses showed reduction in efficacy. Adverse events significantly increased with dose. CONCLUSIONS: With a low dose of antidepressants, clinicians trade off a slightly reduced chance of improvement for a higher chance of avoiding adverse reactions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Data on the effectiveness of antidepressants for depression show that overall only about 50% of patients randomised to active treatment were considered improved using intention-to-treat analyses at post-test.
“However, this accords with data on the effectiveness of antidepressants for depression, where overall only about 50% of patients randomised to active treatment were considered improved using intention to treat analyses at post test [50].”
From Internet-Based CBT for Depression with and without Telephone Tracking in a National Helpline: Randomised Controlled Trial (2011) · cites this paper as [50]
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · see citing works
(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946 · see citing works
Everitt, B. S. (2001) · Psychology Press eBooks · doi:10.4324/9781410605542-11 · Cited by 6,877 · see citing works
Adequacy and Duration of Antidepressant Treatment in Primary Care
Katon, W. J., Korff, M. V., Lin, E. H. B., Bush, T. M., & Ormel, J. (1992) · Medical Care · doi:10.1097/00005650-199201000-00007 · Cited by 519 · see citing works
Ziegel, E. R., Diggle, P., Liang, K., & Zeger, S. (1995) · Technometrics · doi:10.2307/1269941 · Cited by 321 · see citing works
Anderson, I. M., & Tomenson, B. (1995) · BMJ · doi:10.1136/bmj.310.6992.1433 · Cited by 304 · see citing works
Impaired Neuropsychological Performance in Euthymic Patients With Recurring Mood Disorders
Tham, A., Engelbrektson, K., Mathe, A. A., Johnson, L., Olsson, E., & Aberg-Wistedt, A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0105 · Cited by 229 · see citing works
The treatment of depression: prescribing patterns of antidepressants in primary care in the UK
Donoghue, J. M., & Tylee, A. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.2.164 · Cited by 209 · see citing works
Hotopf, M. H., Hardy, R., & Lewis, G. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.2.120 · Cited by 142 · see citing works
Hotopf, M., Lewis, G., & Normand, C. (1997) · Journal of Epidemiology and Community Health · doi:10.1136/jech.51.4.354 · Cited by 130 · see citing works
Meta-analysis of trials comparing antidepressants with active placebos
Moncrieff, J., Wessely, S. C., & Hardy, R. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.3.227 · Cited by 127 · see citing works
Antidepressant drug selection: criteria and options.
Preskorn, S. (1994) · PubMed · Cited by 115 · see citing works
Optimal dose regimen for paroxetine.
Dünner, D. L., & Dunbar, G. C. (1992) · PubMed · Cited by 108 · see citing works
McGee, M. D. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0106e · Cited by 97 · see citing works
Controlled Trial of Amitriptyline in General Practice
Blashki, T. G., Mowbray, R. M., & Davies, B. (1971) · BMJ · doi:10.1136/bmj.1.5741.133 · Cited by 86 · see citing works
The Evidence for 20 mg a day of Fluoxetine as the Optimal Dose in the Treatment of Depression
Altamura, A. C., Montgomery, S., & Wernicke, J. (1988) · The British Journal of Psychiatry · doi:10.1192/s0007125000297377 · Cited by 84 · see citing works
Martin, R. M., Hilton, S. R., Kerry, S., & Richards, N. (1997) · BMJ · doi:10.1136/bmj.314.7081.646 · Cited by 84 · see citing works
Safety and tolerability of the new antidepressants.
Nelson, J. C. (1997) · PubMed · Cited by 76 · see citing works
Clinical pharmacology of bupropion and imipramine in elderly depressives.
Branconnier, R. J., Cole, J. O., Ghazvinian, S., Spera, K. F., Oxenkrug, G. F., & Bass, J. L. (1983) · PubMed · Cited by 66 · see citing works
Venlafaxine in depressed outpatients.
Khan, A., Lf, F., & Rudolph, R. L. (1991) · PubMed · Cited by 66 · see citing works
Efficacy issues with antidepressants.
FAWCETT, J. A., & Barkin, R. L. (1997) · PubMed · Cited by 65 · see citing works
Antidepressants may not assist recovery in practice: a naturalistic prospective survey
Brugha, T. S., Bebbington, P., MacCarthy, B., Sturt, E., & Wykes, T. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03218.x · Cited by 61 · see citing works
Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.
Dunlop, S. R., Dornseif, B. E., Wernicke, J., & Potvin, J. H. (1990) · PubMed · Cited by 59 · see citing works
Bjerkenstedt, L., Edman, G., Flyckt, L., et al. (1985) · Psychopharmacology · doi:10.1007/bf00432703 · Cited by 53 · see citing works
Cs, W., Jm, F., Jl, D., & Heiser, J. F. (1996) · PubMed · Cited by 51 · see citing works
A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
Fabre, L. F., & Putman, H. P. (1987) · PubMed · Cited by 48 · see citing works
FRANK, J. B. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199112000-00012 · Cited by 48 · see citing works
Montgomery, S., RASMUSSEN, J. G. C., Lyby, K., CONNOR, P., & TANGHOSJ, P. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206005-00007 · Cited by 46 · see citing works
Anorexia Nervosa in twins: case report and review.
Halaris, A. E., Stern, W. C., Fleet, J. V. W., et al. (1983) · PubMed · Cited by 40 · see citing works
Prescribing antidepressants in general practice
Kendrick, T. (1996) · BMJ · doi:10.1136/bmj.313.7061.829 · Cited by 38 · see citing works
Schiwy, W., Wr, H., & Delini‐Stula, A. (1989) · PubMed · Cited by 32 · see citing works
Placebo-controlled dose-ranging trial designs in phase II development of nefazodone.
D’Amico, M. F., Roberts, D. L., Robinson, D. S., SCHWIDERSKI, U. E., & Copp, J. (1990) · PubMed · Cited by 31 · see citing works
A pharmacokinetic dose titration study in adult and elderly depressed patients
Hebenstreit, G. F., Fellerer, K., Zöchling, R., et al. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07178.x · Cited by 30 · see citing works
Prescription pattern of antidepressants in out-patient psychiatric practice
Munizza, C., Tibaldi, G., Bollini, P., Pirfo, E., Punzo, F., & Gramaglia, F. (1995) · Psychological Medicine · doi:10.1017/s0033291700035017 · Cited by 28 · see citing works
Self-citationGram, L. F. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199001001-00004 · Cited by 22 · see citing works
Benkert, O., Szegedi, A., & Wetzel, H. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199609000-00004 · Cited by 17 · see citing works
Fluoxetine at 20 mg per day: the recommended and therapeutic dose in the treatment of depression.
Wernicke, J. F., Bosomworth, J. C., & ASHBROOK, E. (1989) · PubMed · Cited by 16 · see citing works
A Comparison of Adinazolam and Desipramine in the Treatment of Major Depression
Kennedy, S. H., de Groot, J., Ralevski, E., et al. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00001 · Cited by 12 · see citing works
Single‐Versus Multiple‐Dose Comparative Trial of Desipramine Hydrochloride: A Double‐Placebo Method
BARNES, R. J., & Guarino, R. A. (1980) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1980.tb01687.x · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160 · see citing works
Efficacy of advance care planning: a systematic review and meta-analysis.
Houben, C. H. M., Spruit, M. A., Groenen, M. T. J., Wouters, E. F. M., & Janssen, D. J. A. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.01.008 · Cited by 765 · see citing works
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · see citing works
Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568 · see citing works
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365 · see citing works
Furukawa, T. A., Cipriani, A., Cowen, P. J., Leucht, S., Egger, M., & Salanti, G. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30217-2 · Cited by 322 · see citing works
Meta-analysis of the dose-response relationship of SSRI in obsessive–compulsive disorder
Bloch, M. H., McGuire, J., Landeros-Weisenberger, A., Leckman, J. F., & Pittenger, C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.50 · Cited by 317 · see citing works
Ruhé, H. G., Huyser, J., Swinkels, J. A., & Schene, A. H. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1203 · Cited by 230 · see citing works
Pharmacological Treatment of Obsessive-Compulsive Disorder
Pittenger, C., & Bloch, M. H. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.05.006 · Cited by 222 · see citing works
Escitalopram versus other antidepressive agents for depression
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532.pub2 · Cited by 190 · see citing works
Serfaty, M. A., Haworth, D., Blanchard, M., Buszewicz, M., Murad, S., & King, M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.165 · Cited by 190 · see citing works
Moreno, S. G., Sutton, A. J., Turner, E. H., Abrams, K. R., Cooper, N. J., Palmer, T. M., & Ades, A. E. (2009) · BMJ · doi:10.1136/bmj.b2981 · Cited by 184 · see citing works
Development of a quality assessment instrument for trials of treatments for depression and neurosis
Moncrieff, J., Churchill, R., Drummond, D. C., & McGuire, H. (2001) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.108 · Cited by 185 · see citing works
Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
Bloch, M. H., Wasylink, S., Landeros-Weisenberger, A., Panza, K. E., Billingslea, E., Leckman, J. F., Krystal, J. H., Bhagwagar, Z., Sanacora, G., & Pittenger, C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.028 · Cited by 162 · see citing works
Fracture Risk From Psychotropic Medications: A Population-Based Analysis
Bolton, J. M., Metge, C., Lix, L., Prior, H., Sareen, J., & Leslie, W. D. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31817d5943 · Cited by 158 · see citing works
Farrer, L., Christensen, H., Griffiths, K. M., & Mackinnon, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028099 · Cited by 140 · see citing works
Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders
Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2019) · Depression and Anxiety · doi:10.1002/da.22854 · Cited by 131 · see citing works
Schuch, F. B., Vasconcelos-Moreno, M. P., Borowsky, C., Zimmermann, A. B., Rocha, N. S., & Fleck, M. P. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.11.005 · Cited by 130 · see citing works
Antidepressant dose, age, and the risk of deliberate self-harm
Miller, M., Swanson, S. A., Azrael, D., Pate, V., & Stürmer, T. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1053 · Cited by 92 · see citing works
Altered Serum Levels of TNF-α, IL-6, and IL-18 in Depressive Disorder Patients
Fan, N., Luo, Y., Ou, Y., & He, H. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2588 · Cited by 85 · see citing works
Pittenger, C., Bloch, M. H., Wasylink, S., Billingslea, E., Simpson, R., Jakubovski, E., Kelmendi, B., Sanacora, G., & Coric, V. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09123 · Cited by 80 · see citing works
Omori, I. M., Murata, Y., Yamanishi, T., Nakaaki, S., Akechi, T., Mikuni, M., & Furukawa, T. A. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.005 · Cited by 74 · see citing works
Severity of generalized social anxiety disorder correlates with low executive functioning
Fujii, Y., Kitagawa, N., Shimizu, Y., Mitsui, N., Toyomaki, A., Hashimoto, N., Kako, Y., Tanaka, T., Asakura, S., Koyama, T., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.059 · Cited by 72 · see citing works
Hashimoto, N., Nakaaki, S., Omori, I. M., Fujioi, J., Noguchi, Y., Murata, Y., Sato, J., Tatsumi, H., Torii, K., Mimura, M., et al. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.08.001 · Cited by 63 · see citing works
Brisch, R., Steiner, J., Mawrin, C., Krzyżanowska, M., Jankowski, Z., & Gos, T. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0774-1 · Cited by 60 · see citing works
Serfaty, M., King, M., Nazareth, I., Moorey, S., Aspden, T., Mannix, K., Davis, S., Wood, J., & Jones, L. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.207 · Cited by 47 · see citing works
Meta-analysis: Risk of dry mouth with second generation antidepressants
Cappetta, K., Beyer, C., Johnson, J. A., & Bloch, M. H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.012 · Cited by 49 · see citing works
Morein-Zamir, S., Papmeyer, M., Gillan, C. M., Crockett, M. J., Fineberg, N. A., Sahakian, B. J., & Robbins, T. W. (2013) · Psychological Medicine · doi:10.1017/s0033291712001018 · Cited by 43 · see citing works
Manic/hypomanic switch during acute antidepressant treatment for unipolar depression
Wada, K., Sasaki, T., Jitsuiki, H., Yoshimura, Y., Erabi, H., Hada, Y., & Yamashita, M. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000237950.65517.be · Cited by 39 · see citing works
Dose-response relationship of recent antidepressants in the short-term treatment of depression
Berney, P. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.3/pberney · Cited by 39 · see citing works
Braun, C., Adams, A., Rink, L., Bschor, T., Kuhr, K., & Baethge, C. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13235 · Cited by 36 · see citing works
Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence
Cellini, L., De Donatis, D., Zernig, G., De Ronchi, D., Giupponi, G., Serretti, A., Xenia, H., Conca, A., & Florio, V. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000386 · Cited by 24 · see citing works
Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder.
Hemels, M. E. H., Vicente, C., Sadri, H., Masson, M. J., & Einarson, T. R. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003197 · Cited by 23 · see citing works
Furukawa, T. A., Onishi, Y., Hinotsu, S., Tajika, A., Takeshima, N., Shinohara, K., Ogawa, Y., Hayasaka, Y., & Kawakami, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.015 · Cited by 21 · see citing works
Moon, S.-Y., Choi, Y. B., Jung, H. K., Lee, Y. I., & Choi, S.-H. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.09.30 · Cited by 19 · see citing works
Safer, D. J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000564 · Cited by 19 · see citing works
Kopřivová, J., Horáček, J., Raszka, M., Brunovský, M., & Praško, J. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.05.015 · Cited by 15 · see citing works
Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine
Koga, M., Kodaka, F., Miyata, H., & Nakayama, K. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01433.x · Cited by 9 · see citing works
Combined Pharmacotherapy and Psychological Treatment for Depression: A Systematic Review
Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.714 · Cited by 5 · see citing works
Self-citation
- Authors
- Bollini, P., Pampaliona, S., Tibaldi, G., Kupelnick, B., & Munizza, C.
- Affiliations
- University of Turin (IT)
- Corresponding author
- Bollini, Paola
- ORCID
- Tibaldi, Giuseppe
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1999-04
- Volume
- 174
- Issue
- 4
- Pages
- 297-303
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2049129528
- Cited by
- 274
- References
- 41
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 8 · 2021: 10 · 2020: 10 · 2019: 6 · 2018: 7 · 2017: 13 · 2016: 15 · 2015: 9 · 2014: 21 · 2013: 10 · 2012: 15
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The British Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, dose-response relationship, antidepressant efficacy, drug tolerability, adverse drug reactions, low-dose antidepressants, depression treatment
- MeSH terms
- Age Factors, Antidepressive Agents, Depressive Disorder, Dose-Response Relationship, Drug, Humans, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review